These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18365217)

  • 1. [Myalgia in Neuro-Behçet's disease. Medication side effects or expression of underlying disease].
    Krämer M; Baumgärtel MW; Neuen-Jacob E; Berlit P
    Z Rheumatol; 2008 May; 67(3):232-6. PubMed ID: 18365217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behçet's disease with a fatal evolution].
    Stan C; Săceleanu AM
    Oftalmologia; 1997; 41(3):228-30. PubMed ID: 9409968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection.
    Vitale A; Rigante D; Caso F; Franceschini R; Cantarini L
    Int J Rheum Dis; 2017 Aug; 20(8):1046-1049. PubMed ID: 26032112
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporin-A therapy in severe uveitis of Behçet's disease.
    Süllü Y; Oge I; Erkan D; Aritürk N; Mohajeri F
    Acta Ophthalmol Scand; 1998 Feb; 76(1):96-9. PubMed ID: 9541443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report.
    Shahram F; Davatchi F; Chams H; Nadji A; Jamshidi A; Akbarian M; Gharibdoost F
    Adv Exp Med Biol; 2003; 528():571-3. PubMed ID: 12918767
    [No Abstract]   [Full Text] [Related]  

  • 6. Optic nerve involvement in neuro-Behcet's disease.
    Nakamura T; Takahashi K; Kishi S
    Jpn J Ophthalmol; 2002; 46(1):100-2. PubMed ID: 11853723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole thoracal spinal cord involvement in case of neuro-Behçet's disease.
    Kabukçu T; Edemci S; Uçan H; Celik C; Gunes HN; Yoldas T
    Rheumatol Int; 2009 Apr; 29(6):707-9. PubMed ID: 18982328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A brain mass in a patient with Behcet's disease: a case report.
    Alfedaghi AS; Masters Y; Mourou M; Eshak O
    J Med Case Rep; 2015 Sep; 9():209. PubMed ID: 26419933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study.
    Zaghetto JM; Yamamoto MM; Souza MB; Silva FT; Hirata CE; Olivalves E; Yamamoto JH
    Arq Bras Oftalmol; 2010; 73(1):40-6. PubMed ID: 20464112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.
    Davatchi F; Sadeghi Abdollahi B; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Faezi T; Akhlaghi M; Ghodsi Z; Ashofteh F; Mohtasham N
    Int J Rheum Dis; 2014 May; 17(4):444-52. PubMed ID: 24314325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study.
    Mohammadi M; Shahram F; Shams H; Akhlaghi M; Ashofteh F; Davatchi F
    Int J Rheum Dis; 2017 Sep; 20(9):1269-1276. PubMed ID: 28524639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term therapy with low dose cyclosporin A in ocular Behçet's disease.
    Ozdal PC; Ortaç S; Taskintuna I; Firat E
    Doc Ophthalmol; 2002 Nov; 105(3):301-12. PubMed ID: 12539855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
    Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
    Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging findings and outcome of neuro-Behçet's disease: the predictive factors.
    Farahangiz S; Sarhadi S; Safari A; Borhani-Haghighi A
    Int J Rheum Dis; 2012 Dec; 15(6):e142-9. PubMed ID: 23253242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system symptoms in a population of Behçet's disease patients with refractory uveitis treated with cyclosporine A.
    Kato Y; Numaga J; Kato S; Kaburaki T; Kawashima H; Fujino Y
    Clin Exp Ophthalmol; 2001 Oct; 29(5):335-6. PubMed ID: 11720163
    [No Abstract]   [Full Text] [Related]  

  • 17. Intracranial hemorrhage in neuro-Behçet's syndrome.
    Kikuchi S; Niino M; Shinpo K; Terae S; Tashiro K
    Intern Med; 2002 Sep; 41(9):692-5. PubMed ID: 12322793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.
    Whitcup SM; Salvo EC; Nussenblatt RB
    Am J Ophthalmol; 1994 Jul; 118(1):39-45. PubMed ID: 8023874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between the parenchymal neurological involvement and posterior uveitis in Behçet's syndrome.
    Bitik B; Tufan A; Sahin K; Sucullu Karadag Y; Can Sandikci S; Mercan R; Ak F; Karaaslan Y; Ozturk MA; Goker B; Haznedaroglu S
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):82-85. PubMed ID: 27791948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of Behçet's disease associated with neuromyopathy induced by combination therapy with colchicine and cyclosporin].
    Fujii Y; Arimura Y; Takahashi N; Toki T; Marumo T; Yoshihara K; Nakabayashi K; Yamada A
    Ryumachi; 2003 Feb; 43(1):44-50. PubMed ID: 12692989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.